Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,979 | 185 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $705.73 | 48 | $0 (2024) |
| Lilly USA, LLC | $536.52 | 33 | $0 (2024) |
| ABBVIE INC. | $352.04 | 20 | $0 (2024) |
| GlaxoSmithKline, LLC. | $237.83 | 17 | $0 (2024) |
| Amgen Inc. | $177.81 | 12 | $0 (2024) |
| Boston Scientific Corporation | $164.96 | 2 | $0 (2024) |
| PFIZER INC. | $149.20 | 8 | $0 (2024) |
| Abbott Laboratories | $138.69 | 9 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $114.30 | 9 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $104.87 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $735.21 | 35 | Novo Nordisk Inc ($213.56) |
| 2023 | $603.36 | 37 | GlaxoSmithKline, LLC. ($144.05) |
| 2022 | $566.03 | 34 | Novo Nordisk Inc ($166.45) |
| 2021 | $160.77 | 10 | AbbVie Inc. ($84.87) |
| 2020 | $53.07 | 3 | Merck Sharp & Dohme Corporation ($22.50) |
| 2019 | $259.11 | 19 | Amgen Inc. ($110.96) |
| 2018 | $250.35 | 20 | Lilly USA, LLC ($65.41) |
| 2017 | $350.76 | 27 | Lilly USA, LLC ($96.05) |
All Payment Transactions
185 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Diabetes Care | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: VACCINES | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: ADHD | ||||||
| 09/16/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: VACCINES | ||||||
| 09/11/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Bone Health | ||||||
| 08/05/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: VACCINES | ||||||
| 05/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Diabetes | ||||||
| 05/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Obesity | ||||||
| 05/14/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: ADHD | ||||||
| 05/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Diabetes Care | ||||||
| 05/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Diabetes | ||||||
| 05/06/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: VACCINES | ||||||
| 05/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Diabetes | ||||||
| 04/23/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Obesity | ||||||
| 03/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Diabetes | ||||||
| 03/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Diabetes | ||||||
| 03/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Obesity | ||||||
| 02/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 457 | 677 | $114,866 | $24,910 |
| 2022 | 12 | 503 | 752 | $139,557 | $29,561 |
| 2021 | 10 | 445 | 688 | $121,177 | $51,477 |
| 2020 | 11 | 372 | 591 | $111,241 | $37,042 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 153 | 352 | $73,568 | $13,975 | 19.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 77 | $10,934 | $3,130 | 28.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 33 | 34 | $4,182 | $2,561 | 61.2% |
| 77067 | Screening mammography | Office | 2023 | 16 | 16 | $3,584 | $1,882 | 52.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 35 | $805.00 | $788.90 | 98.0% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 16 | 16 | $1,488 | $782.40 | 52.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $2,266 | $768.90 | 33.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 89 | 89 | $16,020 | $397.39 | 2.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 34 | 36 | $1,656 | $337.92 | 20.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $363.00 | $286.00 | 78.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 175 | 412 | $86,108 | $16,822 | 19.5% |
| 77067 | Screening mammography | Office | 2022 | 22 | 22 | $4,928 | $2,655 | 53.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 59 | $8,378 | $2,312 | 27.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 33 | 34 | $4,182 | $2,166 | 51.8% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 22 | 22 | $2,046 | $1,095 | 53.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 91 | 91 | $16,380 | $959.49 | 5.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $7,557 | $819.93 | 10.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 34 | 34 | $782.00 | $767.74 | 98.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 22 | 22 | $6,380 | $760.23 | 11.9% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 12 | 13 | $1,300 | $658.29 | 50.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 11 | 11 | $550.00 | $397.18 | 72.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 19 | 21 | $966.00 | $148.13 | 15.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 173 | 407 | $85,063 | $32,910 | 38.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 58 | 58 | $10,440 | $7,277 | 69.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 61 | 68 | $9,656 | $4,171 | 43.2% |
About Dr. Christopher Wright, M.D
Dr. Christopher Wright, M.D is a Family Medicine healthcare provider based in Olathe, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1043207426.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Wright, M.D has received a total of $2,979 in payments from pharmaceutical and medical device companies, with $735.21 received in 2024. These payments were reported across 185 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,979).
As a Medicare-enrolled provider, Wright has provided services to 1,777 Medicare beneficiaries, totaling 2,708 services with total Medicare billing of $142,990. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Olathe, KS
- Active Since 09/30/2005
- Last Updated 01/27/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1043207426
Products in Payments
- Ozempic (Drug) $273.51
- TRULICITY (Drug) $254.65
- MOUNJARO (Drug) $249.22
- Rybelsus (Drug) $216.27
- Resolution 360 Clip (Device) $149.45
- SHINGRIX (Biological) $129.08
- XIFAXAN (Drug) $129.02
- PREVNAR 20 (Biological) $125.45
- AREXVY (Drug) $108.75
- UBRELVY (Drug) $104.16
- EVENITY (Biological) $103.73
- VRAYLAR (Drug) $99.74
- FREESTYLE LIBRE 2 (Device) $91.17
- Xelstrym (Drug) $76.98
- Wegovy (Drug) $73.34
- QULIPTA (Drug) $63.93
- SIVEXTRO (Drug) $56.80
- Saxenda (Drug) $56.55
- JARDIANCE (Drug) $56.29
- JANUVIA (Drug) $46.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Olathe
Constance Irick, M.d, M.D
Family Medicine — Payments: $21,543
Travis Keller, Md, MD
Family Medicine — Payments: $13,363
Dr. Fred Church, D.o, D.O
Family Medicine — Payments: $13,106
Dr. Holly Kaufman, M.d, M.D
Family Medicine — Payments: $12,247
Dr. Anthony Justesen, Md, MD
Family Medicine — Payments: $5,767
Dr. Young Cho, M.d, M.D
Family Medicine — Payments: $5,229